[ET Net News Agency, 4 November 2019] Frontage Holdings Corporation (01521) said its
subsidiary Frontage Laboratories, Inc. has agreed to purchase the entire equity interest
of RMI at a consideration of not more than US$5.55 million.
RMI is a Contract Research Organization (CRO) located in Pennsylvania, USA, principally
engaged in providing quantitative and qualitative drug metabolism services for
pharmaceutical and biotechnology companies. (RC)